Experimental infection with enteropathogenic Escherichia coli identified by PCR using enteric-coated capsules in boxer pups Infecção experimental com Escherichia coli enteropatogênicas, identificadas por PCR utilizando cápsulas com revestimento entérico em filhotes da raça boxer

Autor: Eliana Maria Ferreira Gouveia, Iandara Schettert Silva, Gerson Nakazato, Flábio Ribeiro de Araujo, Marilene Rodrigues Chang

Publikováno v: Acta Cirúrgica Brasileira, Vol 26, Iss 2, Pp 144-148 (2011)

PURPOSE: To verify the possibility of an experimental infection with enteropathogenic Escherichia coli and to confirm by PCR that the symptoms manifested after infection were due to the virulence factors of the studied bacteria. METHODS: Experimental

Externí odkaz: https://doaj.org/article/b63687fb80074dea995298af4277c537

Action of phosphorylated mannanoligosaccharides on immune and hematological responses and fecal consistency of dogs experimentally infected with enteropathogenic Escherichia coli strains

Autor: Marilene Rodrigues Chang, R.A.C. Corrêa, Eliana Maria Ferreira Gouveia, Iandara Schettert Silva, V.J.V. Onselem, Flábio R. Araújo, Gerson Nakazato

Publikováno v: Brazilian Journal of Microbiology, Vol 44, Iss 2, Pp 499-504 (2013)
Repositório Institucional da EMBRAPA (Repository Open Access to Scientific Information from EMBRAPA-Alice)
Empresa Brasileira de Pesquisa Agropecuária (Embrapa)
instacron:EMBRAPA
Brazilian Journal of Microbiology
Brazilian Journal of Microbiology, Volume: 44, Issue: 2, Pages: 499-504, Published: 2013
Brazilian Journal of Microbiology v.44 n.2 2013
Sociedade Brasileira de Microbiologia (SBM)
instacron:SBM

The therapeutic action of phosphorylated mannanoligosaccharides (MOS) was investigated regarding its prebiotic activity on enteropathogenic Escherichia coli (EPEC). Diarrhea was induced in dogs by experimental infection with EPEC strains. Then MOS wa

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::38115e6e5f465cd14aaa7f7f65928a4f
http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1517-83822013000200027&lng=en&tlng=en

Use of mannanoligosacharides as an adjuvant treatment for gastrointestinal diseases and their effects on E.coli inactivated in dogs

Autor: Eliana Maria Ferreira, Gouveia, Iandara Schettert, Silva, Valter Joost Van, Onselem, Rui Alberto Caetano, Corrêa, Camila Junqueira e, Silva

Publikováno v: Acta cirurgica brasileira. 21

To evaluate the effects of mannanoligosacharides on dogs showing gastroenteritis.Sixteen dogs, 2-6 month-old, distributed into two groups: T1--animals with gastroenteritis receiving treatment for the disease + mannanoligosacharides (2 g/animal).; and

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::2b33f8987be23d771723c747d8f2b1fc
https://pubmed.ncbi.nlm.nih.gov/17293961